This meeting will provide an overview of the data presented at the December 2020 ASH virtual meeting which is clinically relevant to myeloma clinics.

This meeting will start with a cutaneous lymphoma workshop with discussion and complex cases, followed by a session focussing on next generation sequencing in lymphoma. Suitable for consultants, trainees, CNS in lymphoma, pharmacists and scientists working in this disease area. The meeting is free of charge to HCPs working within the NHS.

The theme of this virtual meeting is Closer to deciphering disease complexity. Registration is free of charge for HCPs working within the NHS.

Symposium on the contributions by the Anthony Nolan Research Institute to HSCT over 28 years and the current status of innovative cell therapies

This meeting will focus on the impact of COVID on multiple myeloma management. Dr Maheshi Ramasamy will deliver the Michael Morley lecture: COVID, immune dysfunction and vaccination. Registration is free of charge for HCPs working within the NHS.

The programme for this virtual day will be designed to help UK haematology HCPs stay up-to-date with the most relevant new abstracts and data presented at the ASH 2020 meeting.

Chair: Professor Rachael Hough, UCLH

If you are interested to join this group, please email Carly (carly@hartleytaylor.co.uk) in the first instance.

This event will provide attendees with a flavour of the EBMT 47th Annual Meeting, highlighting several key talks and abstracts.

Organising Committee: Dr Hannah Hunter, Dr Fiona Dignan, Dr Victoria Potter, Dr Eleni Tholouli, Dr Rachel Protheroe

Training day for both senior and junior nurses and MDT interested in children and young people’s HSCT in the UK and ROI

Please contact Carly (carly@hartleytaylor.co.uk) to enquire about joining the group.

The 51st Academic Meeting of the UKFHD will include talks on lessons learnt from the COVID 2nd wave, gene therapy, NICE commissioning of new therapies, bone marrow transplant for sickle adults, advising patients on the COVID vaccine, psychology of vaccination and its impact on BAME …. and more.

This meeting will focus on cellular therapy and include invited lectures on the science behind CAR T cells, allogeneic CAR T cells, next generation CAR-NK cells for the treatment of cancer and CAR T therapies in practice – along with the John Goldman abstract prize and CTC/IMPACT lightning updates sessions.

This meeting will combine case presentations with high calibre lectures and discussion to provide an update in the management of follicular lymphoma. Suitable for consultants, trainees, nurses, pharmacists and scientists working in this disease area.

The programme for this meeting has been designed to address the challenges and recurring themes faced by the MDT. The sessions will be case-based with lots of discussion.

This meeting will provide South West delegates with a useful opportunity to share the latest data, best practice and keep up to date with challenges in Acute Leukaemia. Suitable for consultants, trainees, CNS in both AML & ALL as well as pharmacists and scientists working in this disease area. The meeting is free of charge and concludes with a networking supper at the end of the evening.

This study day will focus on the recent advances seen within myeloma, chronic lymphocytic leukemia and myeloproliferations and how diagnostic advances guide the individual patient pathway.

This non-malignant haematology update day will provide a review of the abstracts presented at the latest ISTH and ASH meetings which are most useful for UK practice.

The meeting will provide a comprehensive update on CAR-T cell therapy for haematology nurses.

This meeting will provide South West delegates with a useful opportunity to share latest data, best practice and keep up to date with changes in lymphoma practice. Suitable for consultants, trainees, CNS in lymphoma, pharmacists and scientists working in this disease area. The meeting is free of charge to HCPs working within the NHS and concludes with a networking supper.

Organiser and Chair: Professor Charles Craddock (Birmingham)
Co-Chairs: Dr Mike Dennis (Manchester) & Dr Steve Knapper (Cardiff)

This Autumn meeting of the UK Paediatric BMT Group will combine a clinical trials update day and the annual audit meeting across centres.

This meeting will focus on sequencing therapy and personalised medicine in myeloma

This programme is designed to combine high calibre lectures and interactive discussions to provide an educational opportunity to update clinicians and allied professions in current issues within the management of diseases affecting haematology patients. Suitable for consultants, trainees, nurses, pharmacists and scientists working in haematology.